Last update:

Oncology & Cancer news

Oncology & Cancer

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...

Medications

Drugs approved for treating pain may also reduce bone cancer growth

Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and spinal cord)—are known to infiltrate and grow within malignant bone tumors called osteosarcomas, ...

Oncology & Cancer

In-surgery radiation cuts pancreatic cancer return

Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce ...

Oncology & Cancer

AI tool identifies women at high risk of interval breast cancer

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Oncology & Cancer

Scientists uncover new driver of ovarian cancer spread

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly improve the outlook for women diagnosed with this aggressive disease.

Oncology & Cancer

Why fasting won't cleanse your body—or beat cancer

Every few months, a new "miracle cure" for cancer trends on social media. From superfoods and supplements to extreme diets, the promises are always bold—and almost always misleading. The latest claim suggests that a 21-day ...

Oncology & Cancer

Living tumor-on-a-chip exposes how cancers block immune attacks

For a little over two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients' T cells, re-engineering them to recognize tumor antigens, and infusing ...

Oncology & Cancer

Blocking brain damage may slow glioblastoma growth

Blocking brain damage triggered by a glioblastoma, an aggressive brain cancer, may slow the growth of the cancer and allow the brain to keep working better for longer, according to a new study led by UCL (University College ...

Oncology & Cancer

How HPV reprograms immune cells to help cancer grow

The most common cancer-causing strain of human papillomavirus (HPV), HPV16, undermines the body's defenses by reprogramming immune cells surrounding the tumor, according to new research from the Keck School of Medicine of ...

Oncology & Cancer

New options are advancing rare brain cancer treatment

Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by an unlikely foe: a type of brain tumor called an astrocytoma that tends to afflict younger adults. ...

Oncology & Cancer

The diamonds that could find cancer

University of Warwick researchers have built a new diamond-based magnetic field sensor that could be used to better find tumors through tracing magnetic fluid injected into the body.

Oncology & Cancer

Why preventive mastectomy isn't offered to everyone at risk

When Jesse J, Christina Applegate and Katie Thurston spoke openly about their mastectomies, their candor did more than share private struggles. It highlighted a procedure that, while often life saving, is unevenly available ...

Oncology & Cancer

Mitochondrial antioxidant found to drive breast cancer metastasis

The mitochondria may be the powerhouse of the cell, but mounting evidence suggests this organelle is also a driving force behind cancer. Now, new evidence points to the mitochondrial metabolite glutathione, highlighting its ...

Oncology & Cancer

Promising new combo therapy found for drug-resistant melanoma

A new study from Moffitt Cancer Center may offer a breakthrough for patients with advanced melanoma who don't respond to current immunotherapy treatments. The research, published in the Journal for ImmunoTherapy of Cancer, ...

Medications

How breast cancer drugs exploit genomic fractures in tumors

Studying families with multiple members who had breast cancer first led to the discovery of mutations in BRCA genes. Doctors have since learned that these mutations increase the risk of developing multiple tumor types, including ...